EANS-Adhoc: - 2010/2011 annual financial statements show improved earnings figures - Issue of a bond for EUR 15 million on 31 October 2011

--------------------------------------------------------------------------------
ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro
adhoc with the aim of a Europe-wide distribution. The issuer is solely
responsible for the content of this announcement.
--------------------------------------------------------------------------------

Issue of a bond

27.10.2011

Berlin, 27 October 2011. - Marseille-Kliniken AG (Prime Standard,
ISIN DE 0007783003, MKA) has presented its annual report for the
2010/2011 financial year (balance sheet date 30 June 2011). Revenues
came out to EUR 190.0 million and, due to the change in the scope of
consolidation, fell short of the previous year's figure of EUR 240.7
million. EBIT increased by 33.1 per cent to EUR 5.7 million.
Shareholder's equity on the balance sheet rose by 37.1 per cent to
EUR 34.2 million as a result of the capital increases. This equals an
equity ratio of 17.1 per cent (previous year: 12.6 per cent).
Financial debt was cut back by 8.5 per cent to EUR 57.1 million. The
company expects consolidated EBIT in the current year well in excess
of the previous year's level.

The Management Board, with the approval of the Supervisory Board, has
resolved to issue partial bearer bonds with a total nominal amount of
up to EUR 15,000,000. The partial bonds have a term of two years as
well as an interest rate of 9.5 per cent in the first year and 12.5
per cent in the second year.

Marseille-Kliniken AG intends to use the net proceeds from the issue
to refinance its existing liabilities. The partial bonds are to be
introduced to the Open Market of the Frankfurt Stock Exchange. They
will be issued on 31 October 2011 and placed with institutional
investors in Germany and Europe in the scope of a private placement.

No offer: This release is neither an offer nor a solicitation for an
offer to purchase securities. The securities of Marseille-Kliniken AG
described here are not offered for sale in the United States and are
not registered in accordance with the U.S. Securities Act.

End, ad hoc release

Further inquiry note:
Hildegard Filz
Marseille-Kliniken AG
Sportallee 1
22335 Hamburg
Germany
Tel.: +49-(0)40 / 51459-0
www.marseille-kliniken.com

end of announcement euro adhoc
--------------------------------------------------------------------------------

issuer: Marseille-Kliniken AG
Alte Jakobstraße 79/80
D-10179 Berlin
phone: +49 (0)30 246 32-400
FAX: +49 (0)30 246 32-401
mail: info@marseille-kliniken.de
WWW: http://www.marseille-kliniken.de
sector: Pharmaceuticals
ISIN: DE0007783003
indexes: CDAX, Classic All Share, Prime All Share
stockmarkets: regulated dealing/prime standard: Frankfurt, free trade: Berlin,
Stuttgart, Düsseldorf, regulated dealing: Hamburg
language: English